JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases - Takeaways - MDSpire

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases

  • By

  • Bingrun Li

  • Xiaoting Song

  • Cunhao Shan

  • Junchen He

  • Zihan Wang

  • Katarina Stevanovic

  • Torsten Zuberbier

  • Zuotao Zhao

  • Litao Zhang

  • June 18, 2026

  • 0 min

Share

  • 1

    The JAK-STAT signaling pathway is crucial in the pathogenesis of various inflammatory skin disorders, including atopic dermatitis and psoriasis.

  • 2

    Small molecule JAK inhibitors have shown significant efficacy in treating inflammatory skin diseases, with some already approved for clinical use.

  • 3

    Traditional classifications of inflammatory skin diseases based on T helper cell types are inadequate for guiding targeted therapies.

  • 4

    A proposed functional refinement framework integrates JAK-dependent cytokine modules into the existing Th immune axis for better therapeutic guidance.

  • 5

    Understanding the JAK-STAT pathway enhances the mechanistic insight into inflammatory skin diseases, supporting precision medicine approaches.

Original Source(s)

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases

  • by Bingrun Li, Xiaoting Song, Cunhao Shan, Junchen He, Zihan Wang, Katarina Stevanovic, Torsten Zuberbier, Zuotao Zhao, Litao Zhang

  • June 18, 2026

Related Content

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Case Report: Local injection of an IL-17 inhibitor successfully treats Acrodermatitis continua of Hallopeau and avoids immune shift